1. Generics Bulletin
  2. >>Legal & IP

Teva Inks $100m+ Deal To Settle West Virginia Opioid Claims

Israeli Company ‘Continues To Actively Negotiate A National Settlement’

 
• By Dean Rudge

Teva has struck a further cash-and-medicines settlement agreement to resolve opioid-related claims in the US. A bench trial had been due to start in West Virginia by the end of this month, where Teva is to pay $75m over 15 years plus generic Narcan.

US flag gavel (Stocksnapper/Alamy Stock Photo)
Teva admits no wrongdoing under the settlement • Source: Shutterstock (Alamy Stock Photo)

While a nationwide settlement remains high on its agenda, Teva has struck another US state-level opioid settlement deal, this time in West Virginia, on the eve of a bench trial in the Mountain State.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Generics Bulletin